Badenhorst, D <br/><br/>
Impact of beta2-adrenoreceptor gene variants on cardiac cavity size and systolic function in idiopathic dilated cardiomyopathy.  [electronic resource] 

 -  The pharmacogenomics journal  Oct 2007 
 - 339-45 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1470-269X 
<br/><br/><label>Standard No.: </label>10.1038/sj.tpj.6500426  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin-Converting Enzyme Inhibitors--therapeutic use<br/>Cardiomyopathy, Dilated--drug therapy<br/>Cardiotonic Agents--therapeutic use<br/>Cardiovascular Agents--pharmacology<br/>Case-Control Studies<br/>Digoxin--therapeutic use<br/>Diuretics--therapeutic use<br/>Drug Therapy, Combination<br/>Female<br/>Furosemide--therapeutic use<br/>Gene Frequency<br/>Genetic Predisposition to Disease<br/>Haplotypes<br/>Heart Ventricles--pathology<br/>Humans<br/>Male<br/>Middle Aged<br/>Polymorphism, Restriction Fragment Length<br/>Prospective Studies<br/>Receptors, Adrenergic, beta-2--genetics<br/>Risk Factors<br/>Stroke Volume--drug effects<br/>Systole<br/>Time Factors<br/>Treatment Outcome<br/>Ventricular Function, Left--drug effects<br/>Ventricular Remodeling--drug effects